Table 5.

Summaries of all the AEs reported during the study of safety population (N = 252)

Adverse Events	N	%
Nausea	4	1.6
Device expulsion	3	1.2
Pyrexia	3	1.2
Urinary tract infection	2	0.8
Weight increased	3	1.2
Dysuria	2	0.8
Breast discomfort	2	0.8
Menorrhagia	3	1.2
Metrorrhagia	3	1.2
Vaginal discharge	6	2.4
Vaginal bleeding/spotting	13	5.2
Vulvovaginal pain	2	0.8
Vulvovaginal pruritus	7	2.8

Denominator is the number of subjects in the safety population